0001104659-23-088491.txt : 20230807 0001104659-23-088491.hdr.sgml : 20230807 20230807211703 ACCESSION NUMBER: 0001104659-23-088491 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20230803 FILED AS OF DATE: 20230807 DATE AS OF CHANGE: 20230807 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Hahn Mark W CENTRAL INDEX KEY: 0001408502 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-38067 FILM NUMBER: 231149069 MAIL ADDRESS: STREET 1: 6340 QUADRANGLE DRIVE STREET 2: SUITE 100 CITY: CHAPEL HILL STATE: NC ZIP: 27517 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Verona Pharma plc CENTRAL INDEX KEY: 0001657312 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 000000000 STATE OF INCORPORATION: X0 FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 3 MORE LONDON RIVERSIDE CITY: LONDON STATE: X0 ZIP: SE1 2RE BUSINESS PHONE: 011-44-0-2032834200 MAIL ADDRESS: STREET 1: 3 MORE LONDON RIVERSIDE CITY: LONDON STATE: X0 ZIP: SE1 2RE 4 1 tm2323103-2_4seq1.xml OWNERSHIP DOCUMENT X0508 4 2023-08-03 0 0001657312 Verona Pharma plc VRNA 0001408502 Hahn Mark W 3 MORE LONDON RIVERSIDE LONDON X0 SE1 2RE UNITED KINGDOM 0 1 0 0 Chief Financial Officer 1 Ordinary Shares 2023-08-03 4 S 0 117272 2.539 D 15679864 D Ordinary Shares 2023-08-04 4 S 0 150000 2.4992 D 15529864 D Ordinary Shares 2023-08-07 4 S 0 8616 2.4679 D 15521248 D Reported securities are represented by American Depositary Shares ("ADSs"), each of which represents eight (8) Ordinary Shares of the Issuer. The sales reported in the Form 4 were effected pursuant to a Rule 10b5-1 instruction entered into on March 24, 2022 solely with the intent to cover taxes in connection with the vesting of certain previously reported Restricted Share Units. The price reported represents the sale price of the ADSs divided by eight (8). Consists of (i) 5,911,816 Ordinary Shares underlying Restricted Share Units, each of which represents a contingent right to receive one (1) Ordinary Share of the Issuer (which are represented by 738,977 ADSs); and (ii) 9,609,432 Ordinary Shares underlying 1,201,179 ADSs. /s/ Claire Poll, Attorney-in-fact for Mark Hahn 2023-08-07